PXMBF (Paxman AB) Valuation Rank


PXMBF Paxman AB PXMBF
76 GF Score
Price $3.50
GF Value $4.25
! 3 Warning Signs
View Full Analysis

What is Paxman AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Paxman AB Valuation Rank Related Terms

PXMBF
76GF Score
Paxman AB PXMBF
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Paxman AB (PXMBF) Overvalued in 2026?

Based on GuruFocus' analysis, Paxman AB stock appears to be undervalued. The current stock price of $3.50 is trading 17.6% below its estimated GF Value™ of $4.25.

Key valuation signals for PXMBF:

  • Valuation Rank:
  • GF Value™: $4.25 vs. price of $3.50 (17.6% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the PXMBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Paxman AB Business Description

Other Exchanges PAX:SwedenB0F:Germany
Address Pirgatan 13, Karlshamn, SWE, SE-374 35
Paxman AB is a Sweden-based company engaged in the development of the PAXMAN Scalp Cooling System, which has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The portfolio includes both the Paxman and Digni Capsystems with several installations in hospitals, clinics, and treatment centres world-wide.
76GF Score

Get the complete analysis for PXMBF

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.50
Price
$4.25
GF Value